microbiota | CMAC

microbiota

Microbiota of upper respiratory tract in COVID-19

Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):21-30
10.36488/cmac.2024.1.21-30
The COVID-19 pandemic has provided an additional impetus for studying the respiratory microbiome. Dysbiotic changes resulting from the interaction of the SARS-CoV-2 virus with respiratory tract cells can increase the body’s susceptibility to …

Mechanisms of microbial interactions between probiotic microorganisms and Helicobacter pylori

Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):225-238
10.36488/cmac.2023.3.225-238
This review summarizes the most recent data about the mechanisms of microbial interactions between probiotic microorganisms and H. pylori. The review examines the influence of H. pylori on the gastrointestinal microbiota, interspecific interactions …

Microbiota in the pathogenesis of COPD and its impact on the course of the disease

Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(3):202-212
10.36488/cmac.2022.3.202-212
Chronic obstructive pulmonary disease (COPD) is a serious problem for global health. Infectious agents play a main role in the development of COPD exacerbations. Bacterial colonization of the lower respiratory tract is common in patients with stable …